Pharmaceutical
-
King Street Properties Leases Lexington Facility to Four Pharmaceutical Companies
9-16-2020King Street Properties has fully leased a 214,440-sf research facility in Lexington, Mass., to four pharmaceutical companies.
-
Merck Plans London Discovery Research Centre
9-7-2020Merck is planning to begin construction in late 2021 on the $1.3 billion London Discovery Research Centre in the United Kingdom.
-
Fujifilm Diosynth Biotechnologies Breaks Ground on Advanced Therapies Innovation Center
9-1-2020Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas.
-
Codiak BioSciences Installs G-CON PODs in Clinical Manufacturing Facility
8-19-2020Codiak BioSciences is constructing a 12,000-sf clinical manufacturing center in Lexington, Mass. The project includes the build-out of a leased lab and office building to create a GMP facility for the production of exosome therapeutics.
-
CRISPR Therapeutics Expands Research and Manufacturing Facilities
8-10-2020CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district.
-
Cell and Gene Therapy Catapult Plans COVID-19 Vaccine Production Center
8-5-2020The Cell and Gene Therapy Catapult is planning to create the Manufacturing Innovation Centre in Braintree in the United Kingdom. Supported by £100 million in government funding, the project will enable mass production of a COVID-19 vaccine.
-
DiNAQOR AG Completes Gene Therapy R&D Center
7-31-2020DiNAQOR AG completed construction in July of 2020 on a 9,687-sf R&D center in Schlieren, Switzerland.
-
Carter Winstanley Plans Bioscience Research Building in New Haven
7-29-2020Carter Winstanley is planning to build a $100 million bioscience research building in New Haven, Conn.
-
MilliporeSigma Expands Research and Testing Facilities
7-23-2020MilliporeSigma, a subsidiary of Merck, is planning to expand its existing campus in Buchs, Switzerland, with the construction of a $20 million laboratory for the company's reference materials business. Accommodating 40 employees, the three-story, 12,000-sf struct
-
SiO2 Expands Production Capacity for Vaccine Vials and Syringes
7-18-2020SiO2 Materials Science is investing $163 million to expand its production capacity for vaccine vials and syringes in Auburn, Ala.
